Results 141 to 150 of about 75,243 (298)

Diagnostic and therapeutic approaches of para‐testicular SCRMS in an adolescent patient: A case report

open access: yesUroPrecision, EarlyView.
Abstract Background Para‐testicular rhabdomyosarcoma (RMS) is a rare and aggressive malignancy primarily affecting children and adolescents, with peak incidence between ages 2 and 5 years. Of the histological variants of RMS, the spindle cell type of RMS is particularly uncommon, accounting for approximately 5% of cases.
Kholoud Alabassi   +5 more
wiley   +1 more source

Initial Surgical Results of Subcostal Single‐Port Robotic Lung Resection: A Comparative Analysis With the Multi‐Port Robot

open access: yesWorld Journal of Surgery, EarlyView.
This study demonstrated anatomic lung resection using the da Vinci SP, a novel single‐port robot‐assisted thoracoscopic approach, yields outcomes comparable to those achieved with the da Vinci Xi. ABSTRACT Background The da Vinci SP enables single‐port robot‐assisted thoracoscopic surgery and this modality represents a novel approach to lung resection ...
Teruhisa Kawaguchi   +4 more
wiley   +1 more source

Mortality after treatment of malignant pleural effusions with indwelling pleural catheters versus chemical pleurodesis: a population-based study

open access: yesRespiratory Research
Background Little is known about patient outcomes following treatment of malignant pleural effusions (MPE) in the real-world setting. Research question We aimed to compare post-procedure all-cause mortality between individuals who received indwelling ...
Chanel Kwok   +4 more
doaj   +1 more source

A Zosteriform Papular Cutaneous Eruption

open access: yes
JEADV Clinical Practice, EarlyView.
Silvia Borriello   +8 more
wiley   +1 more source

Open Versus Hybrid and Total Minimally Invasive Transthoracic Ivor Lewis Esophagectomy Following Neoadjuvant FLOT Chemotherapy: An Australian and New Zealand Cohort Study

open access: yesWorld Journal of Surgery, EarlyView.
Retrospective analysis of transthoracic oesophagectomies undertaken between 2017 and 2022 following neoadjuvant FLOT chemotherapy from 22 ANZ centers. The primary endpoint was the rate of major (Clavien‐Dindo grade ≥ 3) postoperative complication.
Brendan Desmond   +37 more
wiley   +1 more source

Interventional oncology in children: Where are we now?

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView.
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel   +1 more
wiley   +1 more source

Implant-prosthetic therapy failure in smoker and nonsmoker patients [PDF]

open access: yes, 2015
Introduction: Implant-prosthetic therapy has predictable success, and the complications are associated with a lot of factors. Smoking cigarettes is reason for different oral diseases, bone loss, loss of soft tissue and teeth, appearance of ...
Bajraktarova Valjakova, Emilija   +5 more
core  

Clinical Outcomes of the POPCORN Study: Pharmacodynamics of Pre‐Operative PD1 CheckpOint Blockade and Receptor Activator of NF‐κB Ligand (RANKL) Inhibition in Non‐Small Cell Lung Cancer (NSCLC)—A Phase 1B/2 Trial

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Expanding on the growing evidence for neoadjuvant immunotherapy in resectable non‐small cell lung cancer, this study explored neoadjuvant nivolumab ± denosumab. Two of the 10 treated patients achieved a pathological complete response. CD8 T‐cell infiltration correlated with pathological response, warranting ongoing translational research to understand ...
Elizabeth Ahern   +11 more
wiley   +1 more source

Pleural myopericytoma: A rare neoplasm in a difficult location [PDF]

open access: yesThe Journal of Thoracic and Cardiovascular Surgery, 2018
Kevin, Hodges   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy